Navigation Links
Onyx Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results
Date:2/23/2011

EMERYVILLE, Calif., Feb. 23, 2011 /PRNewswire/ -- Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) today reported its financial results for the full year and fourth quarter 2010. Onyx reported non-GAAP net income of $39.2 million, or $0.63 per diluted share, for the full year 2010 compared to non-GAAP net income of $54.4 million, or $0.89 per diluted share, for the same period in 2009. Onyx reported a non-GAAP net loss of $17.4 million, or $0.28 per diluted share, for the fourth quarter 2010 compared to non-GAAP net income of $8.8 million, or $0.14 per diluted share, for the same period in 2009. Non-GAAP net income excludes, among other items, adjustments to contingent consideration expense in connection with our acquisition of Proteolix Inc., or Proteolix; employee stock-based compensation expense and non-cash imputed interest expense related to the application of Accounting Standards Codification ("ASC") 470-20.

On a GAAP basis, Onyx reported a net loss of $84.8 million, or $1.35 per diluted share, for the full year 2010 compared to net income of $16.2 million, or $0.27 per diluted share, in the same period in 2009. On a GAAP basis, Onyx reported a net loss of $17.1 million, or $0.27 per diluted share, for the fourth quarter 2010 compared to net loss of $5.5 million, or $0.09 per diluted share, in the same period in 2009. A description of the non-GAAP calculations and reconciliation to comparable GAAP measures is provided in the accompanying table entitled "Reconciliation of GAAP to Non-GAAP Net Income (Loss)."

"Strong Nexavar sales for the fourth quarter and full year 2010 provided accelerated momentum across our business," said N. Anthony Coles, M.D., president and chief executive officer of Onyx. "We start 2011 well positioned to drive our Nexavar and proteasome inhibitor franchises forward. The NDA for carfilzomib in relapsed and refractory multiple myeloma is on track
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... YORK , Sept. 2, 2015 Relmada ... novel therapies for the treatment of chronic pain, announced ... meetings at both the FBR Second Annual Healthcare Conference ... as follows: FBR Second Annual Healthcare Conference ... Boston No presentation, investor ...
(Date:9/2/2015)... CHICAGO , Sept. 2, 2015  Kastle ... developing, and commercializing pharmaceuticals for diseases with high ... appointed 3 executives to key commercial operating positions. ... named Vice President, Commercial; Sean was previously Global ... has been appointed as Director, Commercial Strategy and ...
(Date:9/2/2015)... Sept. 2, 2015  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... immunotherapies, announced today that members of its leadership team ... September, including: , First World Congress ... and Food & Environmental Technologies; Portoroz, Slovenia ... Global Investment Conference; New York, NY ...
Breaking Medicine Technology:Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3OncoSec to Present at Scientific and Investment Conferences in September 2OncoSec to Present at Scientific and Investment Conferences in September 3OncoSec to Present at Scientific and Investment Conferences in September 4OncoSec to Present at Scientific and Investment Conferences in September 5
... Science Corporation,researcher, Dan Tinker, presented evidence at ... DC this week indicating that cognitive,training may ... plasticity-based,Brain Fitness Program (TM) uses adaptive exercises ... exercises are designed to drive generalized,improvements in ...
... on critical enzyme,s regulation may hold key to understanding how to ... MEMPHIS, Tenn., Nov. 19 Scientists at St. ... one of the body,s enzyme workhorses called calpains. , ... function in many cellular processes, including the movement of cells in ...
Cached Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3
(Date:9/2/2015)... ... September 02, 2015 , ... Density measurement is used in ... sample handling makes density measurements more efficient and error-free. The new METTLER TOLEDO ... workflow and the advantages compared to manual sample handling. , The Evolution of ...
(Date:9/2/2015)... ANGELES, CA (PRWEB) , ... September 02, 2015 , ... ... comedy that will feature a plus-size actress as the primary love interest in the ... media, especially television and film, significantly affects how and what we think,” Michael Elliot, ...
(Date:9/2/2015)... ... September 02, 2015 , ... The ... and allopathic medicine, opens its second location this week at 31542 S. Coast ... square feet of lounge space for patients to relax while receiving safe and ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... clinical staffing companies, has completed a recapitalization with new investment partners Beecken ... and Heritage Group each offer extensive expertise and connections within the healthcare ...
(Date:9/2/2015)... Chicago, IL (PRWEB) , ... September 02, 2015 ... ... (COIES) is officially announced today. The two day international investment and business conference ... House Oct 9-11, 2015 in Beijing China. The full-weekend networking conference will feature ...
Breaking Medicine News(10 mins):Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 2Health News:New Video from METTLER TOLEDO Shows the Advantages of Sample Handling Automation in Density Determination 3Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 2Health News:The Hydration Room Opens New Location In Laguna Beach, California 3Health News:The Hydration Room Opens New Location In Laguna Beach, California 4Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 2Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 3Health News:Medical Solutions Completes Recapitalization with Beecken Petty O’Keefe & Company and Heritage Group 4Health News:The 2015 China Overseas Investment and Entrepreneurship Summit (COIES) Announced 2
... 22 /PRNewswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical Co., Inc., (NYSE AMEX: ... Chinese medicine ("TCM") based in Chengdu, China, today,announced that ... when, according,to a preliminary list of additions posted on ... ("Russell") reconstitutes its,comprehensive set of U.S. and global equity ...
... 22 DIA 45th Annual Meeting -- , , News ... In a new report, IDC Health Insights ... healthcare and life science markets, ranked Oracle as the number one vendor ... The Life Science Software Top 10 identifies the 10 leading ...
... VNA,s Hospice of ... ... are the adjectives Hospice of Philadelphia considered when it developed its new free-standing inpatient hospice ... not always possible. Typically, patients requiring acute care must go to a hospital. ...
... , SAN DIEGO, June 22 /PRNewswire-FirstCall/ -- BioMed Realty ... of a new $18 million loan secured by the company,s 9865 ... of 9865 Towne Centre Drive, a state-of-the-art laboratory and office facility, ... has since received LEED(R) Silver certification for Core and Shell from ...
... June 22 United Spinal Association,s ( www.UnitedSpinal.org ) ... region,s premiere lifestyle-enhancing Expo designed to promote active living and independence ... The Independence Expo will be held on Friday, August 7th and ... in Orlando, FL. , , Pre-register at ...
... TAIPEI, Taiwan, June 22 /PRNewswire-Asia/ -- ... announced the signing of a Memorandum of,Understanding (MOU) ... Center (STPI), a non-profit organization under the National,Applied ... provide,direction and support for Taiwan,s Science & Technology ...
Cached Medicine News:Health News:Tianyin Pharmaceutical Co., Inc. Set to Join Russell Microcap(R) Index 2Health News:Tianyin Pharmaceutical Co., Inc. Set to Join Russell Microcap(R) Index 3Health News:Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 2Health News:Market Research Firm Cites Oracle as Top Software Vendor for the Life Sciences Industry 3Health News:Unique Facility Designed for the Comfort of Hospice Patients and Their Families 2Health News:Unique Facility Designed for the Comfort of Hospice Patients and Their Families 3Health News:BioMed Realty Trust Closes New $18 Million Secured Loan 2Health News:BioMed Realty Trust Closes New $18 Million Secured Loan 3Health News:United Spinal Association's 2009 Independence Expo Aug. 7th-8th In Orlando: Improving Life for the Disabled and the Aging 2Health News:Taiwan's Science & Technology Policy Research and Information Center (STPI) and Thomson Reuters Sign MOU of Collaboration to Support Science & Technology Development 2Health News:Taiwan's Science & Technology Policy Research and Information Center (STPI) and Thomson Reuters Sign MOU of Collaboration to Support Science & Technology Development 3
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... AEM Laparoscopic Instruments incorporate a layered design ... shielded and monitored to prevent stray electrosurgical ... caused by insulation failure or capacitive coupling; ... shield built into all AEM Instruments provides ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
Medicine Products: